Processa Pharmaceuticals DPO Ratio 2011-2026 | PCSA

Annual DPO Ratio Processa Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	462	613	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
613	462	537

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Esperion Therapeutics ESPR	7.93 K	$ 3.13	0.39 %	$ 651 M	USA
Exelixis EXEL	148	$ 45.86	3.23 %	$ 12.5 B	USA
Fortress Biotech FBIO	400	$ 2.51	2.03 %	$ 70 M	USA
Galapagos NV GLPG	81.9	$ 28.95	1.97 %	$ 2.69 B	Belgium
Immuron Limited IMRN	597	$ 0.81	2.15 %	$ 6.7 M	Australia
Ionis Pharmaceuticals IONS	815	$ 76.26	1.34 %	$ 12.2 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Kamada Ltd. KMDA	106	$ 8.25	0.49 %	$ 260 M	Israel
Kymera Therapeutics KYMR	46.6	$ 85.73	3.65 %	$ 7.24 B	USA
ACADIA Pharmaceuticals ACAD	75.2	$ 22.93	2.6 %	$ 3.8 B	USA
Liquidia Corporation LQDA	209	$ 42.33	5.48 %	$ 3.64 B	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
MannKind Corporation MNKD	108	$ 4.01	40.03 %	$ 1.23 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	133	$ 23.48	0.26 %	$ 2.99 B	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA